The partnership pairs Novo Nordisk’s expertise in protein therapeutics with Vivtex’s gastrointestinal screening and formulation platform.

Researchers hope to undertake clinical studies in multiple cancers, including ovarian cancer, glioblastoma, and others.

The collaborations will provide Illumina's customers with workflows for genomic disease characterization and spatial mapping.

If you missed our video discussion on AGBT day one, view it here. Don’t miss Julianna LeMieux’s GEN Live on March 2. We deliver a full debrief on the news from AGBT—critical to understanding where NGS ...

Researchers say study identifies location of oligodendrocytes in the brain, and integrates information about gene expression and the structural features of neurons.

Beam is advancing BEAM-304 using an approach in which multiple mutation-specific base editors are developed within a single clinical program.

The Taylor vortex fermenter-extractor-separator is designed for small volume, value-added cellular products and process intensification.

In this GEN webinar, experts from ChemPartner, Philip Clarke, PhD, Hu Liu, PhD, and Greg Liang, MD, will provide an overview of some of the innovative platforms that are shaping the next-generation of ...

Astellas Pharma has agreed to co-develop and co-commercialize Vir Biotechnology’s prostate cancer candidate VIR-5500 through a collaboration that could generate more than $1.7 billion for the San ...

Tamarind’s platform for model coordination and inference enables user-friendly AI tools for life science researchers.

The remote control doesn’t trigger the self-destruction of the CAR T cells, but simply prompts them to disengage from their cancerous targets.

HYDRACs are a class of proteomimetic polymers designed to mark harmful proteins, like MYC and KRAS, for destruction rather than merely block their activity.